Article Text

other Versions

PDF
Randomised controlled trial
Cervical pessary reduces spontaneous delivery before 34 weeks and adverse outcomes in pregnant women with a short cervix
  1. Jack Ludmir
  1. Department of Obstetrics and Gynecology, Pennsylvania Hospital/University of Pennsylvania Health System, Penn Medicine, Philadelphia, Pennsylvania, USA
  1. Correspondence to: Dr Jack Ludmir
    Department of Obstetrics and Gynecology, Pennsylvania Hospital/University of Pennsylvania Health System, Penn Medicine, two Pine East, Pennsylvania Hospital, 800 Spruce St Philadelphia, PA 19107-6192, USA; jaludm{at}uphs.upenn.edu

Statistics from Altmetric.com

Commentary on: Goya M, Pratcorona L, Merced C, et al. Pesario Cervical para Evitar Prematuridad (PECEP) Trial Group. Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial. Lancet 2012;379:1800–6.

Context

Prematurity prevention continues to be one of the biggest challenges in perinatal medicine. Most pregnancies complicated by preterm birth occur in gestations without any historical risk factors. The most effective therapeutic approach for the asymptomatic patient with a short cervix continues to evolve. For over 50 years, the cervical pessary has been used to treat women at risk of cervical insufficiency and preterm delivery. However, the value of the pessary in preventing prematurity in patients without historical risk factors has not been properly studied.

Methods

The cervical pessary in pregnant women with a short cervix (PECEP) trial by Goya and colleagues, represents the …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.